Post-liver transplantation multicentric castleman disease treated with valganciclovir and weaning of immunosuppression

American Journal of Transplantation

Volumn 11, Issue 1, 2011, Pages 169-172

  Lim, E J ^a   Crowley, P ^a   Mitchell, C A ^a   Angus, P W ^a  

^a AUSTIN HOSPITAL   (Australia)

Author keywords

Human herpes virus 8; immunosuppression; interleukin 6; liver transplantation; multicentric Castleman disease; valganciclovir

Indexed keywords

ADEFOVIR; CYCLOSPORIN; HEPATITIS B ANTIBODY; LAMIVUDINE; VALGANCICLOVIR;

ADULT; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DRUG WITHDRAWAL; GRAFT REJECTION; HEPATITIS B; HUMAN; HUMAN HERPESVIRUS 8; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; LIVER TRANSPLANTATION; LYMPHADENOPATHY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

GANCICLOVIR; GIANT LYMPH NODE HYPERPLASIA; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED;

EID: 78650909078     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2010.03366.x     Document Type: Article

References (20)

1. Castleman B, Iverson L, Menedez VP,. Localized mediastinal lymph node hyperplasia resembling thymoma. Cancer 1956; 9: 822-830.
2. Gaba AR, Stein RS, Sweet DL, Variakojis D,. Multicentric giant lymph node hyperplasia. Am J Clin Pathol 1978; 69: 86-90.
3. Peterson B, Frizzera G,. Multicentric Castleman's disease. Semin Oncol 1993; 20: 636-647.
4. Kikuta H, Itakura O, Taneichi K, Kohno M,. Tropism of human herpesvirus 8 for peripheral blood lymphocytes in patients with Castleman's disease. Br J Haematol 1997; 99: 790-793.
5. Dupin N, Gorin I, Deleuze J, Agut H, Huraux JM, Escande JP,. Herpes-like DNA sequences, AIDS-related tumors, and Castleman's disease. N Engl J Med 1995; 333: 798.
6. Verucchi G, Calza L, Trevisani F, et al,. Human herpesvirus-8-related Kaposi's sarcoma after liver transplantation successfully treated with cidofovir and liposomal daunorubicin. Transpl Infect Dis 2005; 7: 34-37.
7. Parravinci C, Corbellino M, Paulli M, et al,. Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman's disease. Am J Pathol 1997; 151: 1517-1522.
8. An J, Lichtenstein AK, Brent G, Rettig MB,. The Kaposi sarcoma-associated herpesvirus (KSHV) induces cellular interleukin 6 expression: Role of the KSHV latency-associated nuclear antigen and the AP1 response element. Blood 2002; 99: 649-654.
9. Yoshizaki K, Matsuda T, Nishimoto N, et al,. Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease. Blood 1989; 74: 1360-1367.
10. Waterston A, Bower M,. Fifty years of multicentric Castleman's disease. Acta Oncologica 2004; 43: 698-704.
11. Kawabata H, Tomosugi N, Kanda J, Tanaka Y, Yoshizaki K, Uchiyama T,. Anti-interleukin 6 receptor antibody tocilizumab reduces the level of serum hepcidin in patients with multicentric Castleman's disease. Haematologica 2007; 92: 857-858.
12. Amin HM, Medeiros LJ, Manning JT, Jones D,. Dissolution of the lymphoid follicle is a feature of the HHV8+ variant of plasma cell Castleman's disease. Am J Surg Pathol 2003; 27: 91-100.
13. Murakami Y, Yamagoe S, Noguchi K, et al,. Ets-1-dependent expression of vascular endothelial growth factor receptors is activated by latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus through interaction with Daxx. J Biol Chem 2006; 281: 28113-28121.
14. Dupin N, Diss TL, Kellam P, et al,. HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma. Blood 2000; 95: 1406-1412.
15. Oksenhendler E, Boulanger E, Galicier L, et al,. High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease. Blood 2002; 99: 2331-2336.
16. Zarate-Osorno A, Medeiros LJ, Danon AD, Neiman RS,. Hodgkin's disease with coexistent Castleman-like histologic features. A report of three cases. Arch Pathol Lab Med 1994; 118: 270-274.
17. Chronowski GM, Ha CS, Wilder RB, Cabanillas F, Manning J, Cox JD,. Treatment of unicentric and multicentric Castleman disease and the role of radiotherapy. Cancer 2001; 92: 670-676.
18. Kedes DH, Ganem D,. Sensitivity of Kaposi's sarcoma-associated herpesvirus replication to antiviral drugs. J Clin Invest 1997; 99: 2082-2086.
19. Casper C, Nichols WG, Huang ML, Corey L, Wald A,. Remission of HHV-8 and HIV-associated multicentric Castleman disease with ganciclovir treatment. Blood 2004; 103: 1632-1634. (Pubitemid 38268952)
20. Boeckle E, Boesmueller C, Wiesmayr S, et al,. Kaposi sarcoma in solid organ transplant recipients: A single center report. Transplant Proc 2005; 37: 1905-1909.